Savient Pharmaceuticals, Inc. (SVNT) Reports Second Quarter 2013 Financial Results  
8/14/2013 6:33:27 AM

Regeneron may be hiring! Check it out! (Isn't it tempting?)

BRIDGEWATER, N.J., Aug. 14, 2013 /PRNewswire/ -- Savient Pharmaceuticals, Inc. (SVNT) today reported financial results for the three and six-month periods ended June 30, 2013. Net sales for KRYSTEXXA® were $6.1 million for the second quarter of 2013, a 38% increase over the first quarter of 2013.

Help employers find you! Check out all the jobs and post your resume.